5[1]Brendler CB,Steiberg GD,Marshall FF,et al. Local recurrence and survival following nerve-sparing radical cystoprotectomy[J]. J Urol,1990,144:1137.
6[2]Hautmann RE, Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?[J]. J Urol, 1998,159:1845-1850.
7[4]Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome[J]. J Clin Oncol, 1998, 16:1298-1301.
8[6]Zietman AL, Shipley WU, Kaufman DS, et al. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer[J]. J Urol, 1998,160:1673-1677.
9[12]Sternberg CN, Yagoda A,Scher HI,et al. Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium:efficacy,paterns of response and relapse[J]. Cancer,1998,142:289.
10[13]Serretta V, Lo Greco G, Pavone C, et al. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience[J]. J Urol, 1998 , 159:1187-1191.
